LYC-53976

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLYC-53976
Drug Alias NameLYC-53976
ClassificationSmall molecules
Mechanisms of ActionRho-associated protein kinase 2 inhibitors
TargetsRho-associated protein kinase 2
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLycera Corp
China Registration ClassN/A

Develop Information

Active CompaniesLycera Corp
Inactive CompaniesN/A
Active IndicationsFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A